Pregnant women with heart disease should give birth before 40 weeks

Female heart patients should give birth at no later than 40 weeks gestation, beyond that harm can be caused to the mother, new guidelines by the European Society of Cardiology (ESC) recommends.

Besides pre-pregnancy risk assessment and counselling, a delivery plan should be devised at 20-30 weeks, specifying vaginal or caesarean delivery, whether an epidural or forceps will be used, and the duration of hospital stay after delivery, the guidelines said.

“Pregnancy is a risky period for women with heart disease because it puts additional stress on the heart, so the guidelines advise inducing labour or a caesarean section at 40 weeks,” said Jolien Roos-Hesselink, Professor at the Erasmus University in Rotterdam, Netherlands.

“Beyond 40 weeks, pregnancy has no added benefit for the baby and may even have negative effects,” Roos-Hesselink added.

Heart disease is the main reason women die during pregnancy in western countries, because they have a 100-fold greater risk of death or heart failure than their healthy peers.

An estimated 18-30 per cent of the offsprings have complications and up to 4 per cent of neonates die.

The new guidelines, published in the European Heart Journal, also recommended against in vitro fertilisation (IVF), contraception, and termination of pregnancy for women with heart disease.

It is because IVF often uses high doses of hormones, which increases the risk of thrombosis and heart failure, so women with heart diseases need a cardiologist’s confirmation.

“Since carrying more than one baby puts more stress on the heart, women with heart disease undergoing IVF are strongly advised to transfer a single embryo,” the guidelines said.

While women with heart disease can have a healthy pregnancy, they should be aware of a higher risk of obstetric complications including premature labour, pre-eclampsia, and post-partum bleeding.

Moreover, girls with congenital heart disease should take advice before using contraceptives because some methods are contraindicated in patients with certain types of heart disease, the guidelines noted.


Chemotherapy may lead to early menopause in women with lung cancer

Chemotherapy,Chemotherapy study,Study on Chemotherapy

Chemotherapy may cause acute amenorrhea leading to early menopause in women with lung cancer, according to a new study.

The study is the first to comment on amenorrhea rates in women below 50. It concludes that women with lung cancer, who desire future fertility, should be educated about risks and options before starting treatment.

Premenopausal women with lung cancer may want children and should consult their healthcare providers about options for embryo and oocyte cryopreservation, the gold standard for fertility preservation.

The study included 182 premenopausal women (average age at diagnosis, 43 years). The Mayo Clinic Epidemiology and Genetics of Lung Cancer Research Program surveyed women between 1999 and 2016 at diagnosis and annually thereafter about their menstrual status. Types of lung cancer treatments were recorded, and frequencies of self-reported menopause at each survey were calculated.

The results suggested that chemotherapy for patients with lung cancer increases the risk of the early loss of menses in survivors.

Executive director of NAMS, Dr. JoAnn Pinkerton said, “Although more definitive research is needed, premenopausal women who need chemotherapy for lung cancer appear to have a similar risk of amenorrhea, early menopause, and loss of fertility as premenopausal women receiving chemotherapy for breast cancer and lymphoma.”

“I agree that premenopausal patients with lung cancer need to be educated about the risk for chemotherapy-related amenorrhea, menopause issues (hot flashes, vaginal dryness, and bone loss), and the potential loss of fertility before chemotherapy is initiated,” he added.

The full findings are present in Menopause: The Journal of the North American Menopause Society.


Internshala Launches Career (Re)Launch Campaign For Women To Re-Start Their Career

Internshala Launches Career (Re)Launch Campaign For Women To Re-Start Their Career

Internshala has launched a campaign, ‘Career (Re)Launch: Internship Fair for Women’, specifically for women who want to re-start their career. As part of this campaign, 12 companies including Godrej Consumer Products, Airtel, Shoppers Stop, and Uber are offering internships in the fields of Content Writing, Business Development, HR, etc. Women can apply to these internships till December 10, and selected women candidates can earn a stipend of INR 5,000 to INR 50,000 per month while doing these internships.

This campaign is a part of Internshala’s initiative ‘Internships for Women’ which brings internships for women who have been out of the workforce to help them (re)start their career.

Currently, only 27% of Indian women are a part of the workforce, and to bridge this gender gap at work, organisations across the country are taking various steps such as introducing work from home, flexible work hours, and maternity leaves.

Internship programs for women is one such popular step which companies have taken up. Internships are of short-term duration and provide flexible working options to women. Further, many companies even offer jobs to women after the successful completion of their internships. On Internshala, more than 3,500 women have found internships and have (re)started their career in the last one year.

“As an internship platform when we realised that internships can be a powerful medium for women to (re)start their career, we were enthused to encourage more and more women to opt for them. But what also lifted our enthusiasm was seeing that companies were very willing to come forward and hire women as interns. Career (Re)Launch is an exciting opportunity for women to (re)start their career with renowned brands and exciting stipend”, says Sarvesh Agrawal, CEO, Internshala.